Three developments are converging to make 2026 a pivotal year for dermatology compounding: the FDAs peptide reclassification is restoring access to key molecules used in skin and wound healing, tightening quality standards are separating accredited pharmacies from the rest, and digital prescribing platforms are finally eliminating the operational friction that has kept many dermatologists from incorporating compounding into their standard workflow
IMMUNE BOOSTER Designed to strengthen the bodys immune systems, reduce susceptibility to colds and the flu, and speed up the bodys healing process
In fact, through immune regulation, the growth of cancer can be inhibited (127)
Our approach includes: Clinical evaluation before prescribing : We assess your health history, current medications, lab results, and treatment goals before recommending any peptide therapy
Note the irregularity in secondary structure